Cargando…
The Impact of Intracytoplasmic Sperm Injection in Non-Male Factor Infertility—A Critical Review
Intracytoplasmic sperm injection (ICSI) was originally designed to overcome barriers due to male factor infertility. However, a surveillance study found that ICSI use in non-male factor infertility increased from 15.4% to 66.9% between 1996 and 2012. Numerous studies have investigated fertilization...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231975/ https://www.ncbi.nlm.nih.gov/pubmed/34198564 http://dx.doi.org/10.3390/jcm10122616 |
_version_ | 1783713539253338112 |
---|---|
author | Glenn, Tanya L. Kotlyar, Alex M. Seifer, David B. |
author_facet | Glenn, Tanya L. Kotlyar, Alex M. Seifer, David B. |
author_sort | Glenn, Tanya L. |
collection | PubMed |
description | Intracytoplasmic sperm injection (ICSI) was originally designed to overcome barriers due to male factor infertility. However, a surveillance study found that ICSI use in non-male factor infertility increased from 15.4% to 66.9% between 1996 and 2012. Numerous studies have investigated fertilization rate, total fertilization failure, and live birth rate per cycle (LBR), comparing the use of ICSI versus conventional in vitro fertilization (IVF) for non-male factor infertility. The overwhelming conclusion shows no increase in fertilization rate or LBR per cycle with the use of ICSI for non-male factor infertility. The overuse of ICSI is likely related to the desire to avoid a higher rate of total fertilization failure in IVF. However, data supporting the benefit of using ICSI for non-male factor infertility is lacking, and 33 couples would need to be treated with ICSI unnecessarily to avoid one case of total fertilization failure. Such practice increases the cost to the patient, increases the burden on embryologist’s time, and is a misapplication of resources. Additionally, there remains conflicting data regarding the safety of offspring conceived by ICSI and potential damage to the oocyte. Thus, the use of ICSI should be limited to those with male factor infertility or a history of total fertilization factor infertility due to uncertainties of potential adverse impact and lack of proven benefit in non-male factor infertility. |
format | Online Article Text |
id | pubmed-8231975 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-82319752021-06-26 The Impact of Intracytoplasmic Sperm Injection in Non-Male Factor Infertility—A Critical Review Glenn, Tanya L. Kotlyar, Alex M. Seifer, David B. J Clin Med Review Intracytoplasmic sperm injection (ICSI) was originally designed to overcome barriers due to male factor infertility. However, a surveillance study found that ICSI use in non-male factor infertility increased from 15.4% to 66.9% between 1996 and 2012. Numerous studies have investigated fertilization rate, total fertilization failure, and live birth rate per cycle (LBR), comparing the use of ICSI versus conventional in vitro fertilization (IVF) for non-male factor infertility. The overwhelming conclusion shows no increase in fertilization rate or LBR per cycle with the use of ICSI for non-male factor infertility. The overuse of ICSI is likely related to the desire to avoid a higher rate of total fertilization failure in IVF. However, data supporting the benefit of using ICSI for non-male factor infertility is lacking, and 33 couples would need to be treated with ICSI unnecessarily to avoid one case of total fertilization failure. Such practice increases the cost to the patient, increases the burden on embryologist’s time, and is a misapplication of resources. Additionally, there remains conflicting data regarding the safety of offspring conceived by ICSI and potential damage to the oocyte. Thus, the use of ICSI should be limited to those with male factor infertility or a history of total fertilization factor infertility due to uncertainties of potential adverse impact and lack of proven benefit in non-male factor infertility. MDPI 2021-06-14 /pmc/articles/PMC8231975/ /pubmed/34198564 http://dx.doi.org/10.3390/jcm10122616 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Glenn, Tanya L. Kotlyar, Alex M. Seifer, David B. The Impact of Intracytoplasmic Sperm Injection in Non-Male Factor Infertility—A Critical Review |
title | The Impact of Intracytoplasmic Sperm Injection in Non-Male Factor Infertility—A Critical Review |
title_full | The Impact of Intracytoplasmic Sperm Injection in Non-Male Factor Infertility—A Critical Review |
title_fullStr | The Impact of Intracytoplasmic Sperm Injection in Non-Male Factor Infertility—A Critical Review |
title_full_unstemmed | The Impact of Intracytoplasmic Sperm Injection in Non-Male Factor Infertility—A Critical Review |
title_short | The Impact of Intracytoplasmic Sperm Injection in Non-Male Factor Infertility—A Critical Review |
title_sort | impact of intracytoplasmic sperm injection in non-male factor infertility—a critical review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231975/ https://www.ncbi.nlm.nih.gov/pubmed/34198564 http://dx.doi.org/10.3390/jcm10122616 |
work_keys_str_mv | AT glenntanyal theimpactofintracytoplasmicsperminjectioninnonmalefactorinfertilityacriticalreview AT kotlyaralexm theimpactofintracytoplasmicsperminjectioninnonmalefactorinfertilityacriticalreview AT seiferdavidb theimpactofintracytoplasmicsperminjectioninnonmalefactorinfertilityacriticalreview AT glenntanyal impactofintracytoplasmicsperminjectioninnonmalefactorinfertilityacriticalreview AT kotlyaralexm impactofintracytoplasmicsperminjectioninnonmalefactorinfertilityacriticalreview AT seiferdavidb impactofintracytoplasmicsperminjectioninnonmalefactorinfertilityacriticalreview |